PL118443B1 - Process for preparing novel derivatives of phtalazinyl-4-acetic acidojj kisloty - Google Patents

Process for preparing novel derivatives of phtalazinyl-4-acetic acidojj kisloty Download PDF

Info

Publication number
PL118443B1
PL118443B1 PL1978222157A PL22215778A PL118443B1 PL 118443 B1 PL118443 B1 PL 118443B1 PL 1978222157 A PL1978222157 A PL 1978222157A PL 22215778 A PL22215778 A PL 22215778A PL 118443 B1 PL118443 B1 PL 118443B1
Authority
PL
Poland
Prior art keywords
formula
fluoro
compounds
hydrogen
atom
Prior art date
Application number
PL1978222157A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL118443B1 publication Critical patent/PL118443B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL1978222157A 1977-12-29 1978-12-16 Process for preparing novel derivatives of phtalazinyl-4-acetic acidojj kisloty PL118443B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5414277 1977-12-29

Publications (1)

Publication Number Publication Date
PL118443B1 true PL118443B1 (en) 1981-10-31

Family

ID=10470067

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978222157A PL118443B1 (en) 1977-12-29 1978-12-16 Process for preparing novel derivatives of phtalazinyl-4-acetic acidojj kisloty

Country Status (31)

Country Link
US (2) US4251528A (enExample)
EP (1) EP0002895B1 (enExample)
JP (2) JPS5495582A (enExample)
AT (1) AT365581B (enExample)
AU (1) AU516264B2 (enExample)
BG (1) BG34336A3 (enExample)
CA (1) CA1107732A (enExample)
CS (1) CS241015B2 (enExample)
CY (1) CY1219A (enExample)
DD (1) DD141021A5 (enExample)
DE (1) DE2861170D1 (enExample)
DK (1) DK151253C (enExample)
ES (1) ES476496A1 (enExample)
FI (1) FI64357C (enExample)
GR (1) GR65303B (enExample)
HK (1) HK22484A (enExample)
HU (1) HU182585B (enExample)
IE (1) IE47592B1 (enExample)
IL (1) IL56099A0 (enExample)
IN (1) IN150196B (enExample)
IT (1) IT1110885B (enExample)
MY (1) MY8500359A (enExample)
NO (1) NO154346C (enExample)
NZ (1) NZ189034A (enExample)
PH (1) PH15435A (enExample)
PL (1) PL118443B1 (enExample)
PT (1) PT68956A (enExample)
SG (1) SG68683G (enExample)
SU (3) SU1087075A3 (enExample)
YU (3) YU41607B (enExample)
ZW (1) ZW24978A1 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
CA1143733A (en) * 1979-07-31 1983-03-29 Masao Yoshida Producing 7-alkoxycarbonyl-6,8-dimethyl-4- hydroxymethyl-1-phthalazone and intermediates
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
EP0222576B1 (en) * 1985-11-07 1992-03-18 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
WO1993013092A1 (en) * 1986-11-24 1993-07-08 Reinhard Sarges Imidazolidinedione derivatives
GB8704569D0 (en) * 1987-02-26 1987-04-01 Ici America Inc Therapeutic agent
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
EP0315249A1 (en) * 1987-11-02 1989-05-10 Merck & Co. Inc. Phthalazineacetic acid composition and tablet
DK607188A (da) * 1987-11-02 1989-06-22 Merck & Co Inc Tablet indeholdende en phthalazineddikesyreforbindelse
US4880928A (en) * 1987-12-21 1989-11-14 Merck & Co., Inc. Process for the preparation of 3-((4-bromo-2-fluorophenyl)methyl)-3,4-dihydro-4-oxo-1-phthalazine-acetic acid
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4940791A (en) * 1988-02-29 1990-07-10 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel hydrazine containing intermediate
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
EP0397930A1 (en) * 1989-05-18 1990-11-22 Merck & Co. Inc. Process for the preparation of 3-[(4-bromo-2-fluorophenyl) methyl]-3,4-dihydro-4-oxo-1-phthalazineacetic acid
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
FI922308A0 (fi) * 1989-12-15 1992-05-21 Pfizer Substituerade oxoftalazinylaettiks- syror och deras analoger.
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
CA2145640C (en) * 1992-09-28 2001-01-30 Banavara L. Mylari Substituted pyrimidines for control of diabetic complications
WO1994010151A1 (en) * 1992-11-02 1994-05-11 Merck & Co., Inc. Substituted phthalazinones as nerotensin antagonists
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
JPH09506068A (ja) * 1993-07-26 1997-06-17 藤沢薬品工業株式会社 悪液質治療のためのオキソフタラジン類
AU6473898A (en) * 1997-03-21 1998-10-20 Regents Of The University Of California, The Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors
US6696407B1 (en) 1997-03-21 2004-02-24 The Regents Of The University Of California Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
GEP20022788B (en) * 1997-04-15 2002-09-25 Csir Za Pharmaceutical Compositions Having Appetite Suppressant Activity
HUP0101672A3 (en) * 1998-03-31 2002-05-28 Inst For Pharm Discovery Inc Substituted indolealkanoic acids
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
DE19963607B4 (de) * 1999-12-23 2005-12-15 Schering Ag Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
KR20030059287A (ko) * 2000-11-30 2003-07-07 화이자 프로덕츠 인코포레이티드 Ｇａｂａ 작용제 및 알도스 리덕타제 억제제의 혼합물
ATE297902T1 (de) 2001-02-28 2005-07-15 Pfizer Prod Inc Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
SI1373259T1 (en) 2001-03-30 2005-04-30 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
HUP0303920A3 (en) * 2001-04-30 2004-07-28 Pfizer Prod Inc Pharmaceutical compositions containing combinations of aldose reductase inhibitor pyridazinons and cyclooxygenase 2 inhibitors
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
AU2003233198A1 (en) * 2002-04-30 2003-11-17 Novartis Ag Method for decreasing capillary permeability in the retina
CA2493755A1 (en) * 2002-07-26 2004-02-05 The Institutes For Pharmaceutical Discovery, Llc Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
JP4838582B2 (ja) * 2004-12-27 2011-12-14 岐阜プラスチック工業株式会社 台車用本体
EP2368560A1 (en) 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos
US8273746B2 (en) * 2007-03-23 2012-09-25 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
CN103547261A (zh) 2010-12-23 2014-01-29 德克萨斯大学系统董事会 用于治疗copd的方法
EP2931280B1 (en) * 2012-12-14 2018-02-14 Phusis Therapeutics Inc. Methods and compositions for inhibiting cnksr1
US10227356B2 (en) 2015-04-20 2019-03-12 Phusis Therapeutics, Inc. Compounds, compositions and methods for inhibiting CNKSR1
WO2019165195A1 (en) 2018-02-22 2019-08-29 Srivastava Satish Combination therapy for the treatment of cancer
KR102857329B1 (ko) * 2018-10-04 2025-09-10 닛토덴코 가부시키가이샤 내열 이형 시트 및 열 압착 방법
JP6751974B1 (ja) * 2019-10-16 2020-09-09 株式会社コバヤシ 離型フィルム及び離型フィルムの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833579A (en) * 1935-11-11 1974-09-03 Inoue Michiro 4-carbamoyl phthalazones
JPS5116430B2 (enExample) * 1971-08-05 1976-05-24
GB1398549A (en) * 1972-11-06 1975-06-25 Boots Co Ltd Phthalazine derivatives and their use in pharmaceutical compo sitions
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
DE2451117A1 (de) * 1973-10-31 1975-05-22 Boots Co Ltd Therapeutisch wirksame verbindungen
GB1502312A (en) 1975-03-20 1978-03-01 Ici Ltd Quinolone derivatives
IE43079B1 (en) * 1975-03-20 1980-12-17 Ici Ltd Quinolone derivatives
JPS5214788A (en) * 1975-07-21 1977-02-03 Fuji Photo Film Co Ltd Process for preparing phthalazinone and its derivatives
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof

Also Published As

Publication number Publication date
DK541878A (da) 1979-06-30
YU42807B (en) 1988-12-31
DE2861170D1 (en) 1981-12-24
CY1219A (en) 1984-04-06
HU182585B (en) 1984-02-28
ES476496A1 (es) 1979-04-16
EP0002895A1 (en) 1979-07-11
DK151253C (da) 1988-05-16
SU1272984A3 (ru) 1986-11-23
DD141021A5 (de) 1980-04-09
CA1107732A (en) 1981-08-25
YU232182A (en) 1983-01-21
US4251528A (en) 1981-02-17
SG68683G (en) 1984-08-03
NO784397L (no) 1979-07-02
IT1110885B (it) 1986-01-06
IL56099A0 (en) 1979-01-31
IE782337L (en) 1979-06-29
FI64357B (fi) 1983-07-29
PT68956A (en) 1979-01-01
ATA937678A (de) 1981-06-15
NO154346B (no) 1986-05-26
GR65303B (en) 1980-08-01
YU232082A (en) 1983-01-21
JPH0262532B2 (enExample) 1990-12-26
PH15435A (en) 1983-01-18
IN150196B (enExample) 1982-08-14
EP0002895B1 (en) 1981-10-14
NO154346C (no) 1986-09-03
DK151253B (da) 1987-11-16
YU41607B (en) 1987-12-31
CS241015B2 (en) 1986-03-13
FI64357C (fi) 1983-11-10
HK22484A (en) 1984-03-23
US4393062A (en) 1983-07-12
ZW24978A1 (en) 1980-10-22
IE47592B1 (en) 1984-05-02
FI783844A7 (fi) 1979-06-30
AU516264B2 (en) 1981-05-28
MY8500359A (en) 1985-12-31
YU42054B (en) 1988-04-30
IT7852480A0 (it) 1978-12-28
JPS63119469A (ja) 1988-05-24
JPS6326110B2 (enExample) 1988-05-27
BG34336A3 (bg) 1983-08-15
AT365581B (de) 1982-01-25
NZ189034A (en) 1981-11-19
JPS5495582A (en) 1979-07-28
YU312778A (en) 1983-01-21
SU1072803A3 (ru) 1984-02-07
SU1087075A3 (ru) 1984-04-15
AU4204078A (en) 1979-07-05

Similar Documents

Publication Publication Date Title
PL118443B1 (en) Process for preparing novel derivatives of phtalazinyl-4-acetic acidojj kisloty
Bozsing et al. Synthesis and pharmacological study of new 3, 4-dihydro-2H, 6H-pyrimido-[2, 1-b][1, 3] thiazines
PT98292A (pt) Processo para a preparacao de heterociclos tioxo e de composicoes farmaceuticas que os contem
US5100914A (en) Arylalkoxycoumarins
FR2554817A1 (fr) Nouveaux derives de la vinyl-6 furo-(3,4-c)-pyridine ainsi que leur procede de preparation
CA1142943A (en) 4-guanidinomethylcyclohexane carboxylic acid compounds
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US4970301A (en) 2-(piperazinyl)-2-oxoethylene-substituted flavonoid compounds
AU644082B2 (en) Indenoindole compounds
CA1228862A (en) Azulene derivatives, processes of their synthesis and their uses as anti-ulcerative and anti-inflammatory agents
JPH0576946B2 (enExample)
US3754090A (en) Pharmaceutical compositions and methods for substituted phenethyl alcohols and their esters
KR820001929B1 (ko) 프탈라진-4-일아세트산의 제조방법
PL118444B1 (en) Process for preparing novel derivatives of phtalazinyl-4-acetic acidh-uksusnojj kisloty
KR820001930B1 (ko) 프탈라진-4-일아세트산 유도체의 제조방법
US4181740A (en) Indolyl acetic acid derivative
NO812527L (no) Fremgangsmaate for fremstilling av nye derivater av tiazolo-(3,2-a)pyrimidin.
FR2478094A1 (fr) Derives de cinnamylmoranoline a substitution ammonio, a activite d'inhibition de l'augmentation de niveau de sucre dans le sang
CZ357190A3 (en) Dihydropyrimidothiazine derivatives, process of their preparation and pharmaceutical compositions containing thereof
CS241042B2 (cs) Způsob výroby derivátů 2-be.nzyl-l,2-dihydro-l-oxoftalazin-4-yloctové kyseliny -
Domer et al. Synthesis, biological activity, and structure-activity/toxicity relationships of a series of terphenyl analogs of hemicholinium-3 and acetyl-seco-hemicholinium-3. 3
KR820001931B1 (ko) 프탈라진-4-일 아세트산 유도체의 제조방법
Dygos et al. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives
HU208975B (en) Process for producing imidazo/5,1-b/ quinazolin-9-one derivatives and pharmaceutically acceptable salts thereof, as well as thrombocyta aggregation inhibiting pharmaceutical compositions comprising such active ingredients
BE885264A (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique